144 related articles for article (PubMed ID: 10800396)
1. Lymphohistiocytoid mesothelioma. An often misdiagnosed variant of sarcomatoid malignant mesothelioma.
Khalidi HS; Medeiros LJ; Battifora H
Am J Clin Pathol; 2000 May; 113(5):649-54. PubMed ID: 10800396
[TBL] [Abstract][Full Text] [Related]
2. Calretinin, thrombomodulin, CEA, and CD15: a useful combination of immunohistochemical markers for differentiating pleural epithelial mesothelioma from peripheral pulmonary adenocarcinoma.
Comin CE; Novelli L; Boddi V; Paglierani M; Dini S
Hum Pathol; 2001 May; 32(5):529-36. PubMed ID: 11381372
[TBL] [Abstract][Full Text] [Related]
3. Malignant mesothelioma: immunohistochemistry and DNA ploidy analysis as methods to differentiate mesothelioma from benign reactive mesothelial cell proliferation and adenocarcinoma in pleural and peritoneal effusions.
Friedman MT; Gentile P; Tarectecan A; Fuchs A
Arch Pathol Lab Med; 1996 Oct; 120(10):959-66. PubMed ID: 12046609
[TBL] [Abstract][Full Text] [Related]
4. [Immunohistochemistry in the differential diagnosis of mesothelioma and adenocarcinoma. Evaluation of 5 new antibodies and 6 traditional antibodies].
Chenard-Neu MP; Kabou A; Mechine A; Brolly F; Orion B; Bellocq JP
Ann Pathol; 1998 Dec; 18(6):460-5. PubMed ID: 10051912
[TBL] [Abstract][Full Text] [Related]
5. Lymphohistiocytoid variant of malignant mesothelioma of the pleura: a series of 22 cases.
Galateau-Sallé F; Attanoos R; Gibbs AR; Burke L; Astoul P; Rolland P; Ilg AG; Pairon JC; Brochard P; Begueret H; Vignaud JM; Kerr K; Launoy G; Imbernon E; Goldberg M
Am J Surg Pathol; 2007 May; 31(5):711-6. PubMed ID: 17460454
[TBL] [Abstract][Full Text] [Related]
6. In search of a positive immunohistochemical marker for mesothelioma: an update.
Ordóñez NG
Adv Anat Pathol; 1998 Jan; 5(1):53-60. PubMed ID: 9868512
[No Abstract] [Full Text] [Related]
7. Lymphohistiocytoid mesothelioma of the pleura: a case report with cytological findings.
Tresserra F; Castella M; Fabra G; Angeles Martinez M; Dominguez M; Fernandez-Cid C; Amalrich MD; Ramos C
Diagn Cytopathol; 2013 Jun; 41(6):546-9. PubMed ID: 22021116
[TBL] [Abstract][Full Text] [Related]
8. The value of calretinin and cytokeratin 5/6 as markers for mesothelioma in cell block preparations of serous effusions.
Shield PW; Koivurinne K
Cytopathology; 2008 Aug; 19(4):218-23. PubMed ID: 17916095
[TBL] [Abstract][Full Text] [Related]
9. Value of the mesothelium-associated antibodies thrombomodulin, cytokeratin 5/6, calretinin, and CD44H in distinguishing epithelioid pleural mesothelioma from adenocarcinoma metastatic to the pleura.
Cury PM; Butcher DN; Fisher C; Corrin B; Nicholson AG
Mod Pathol; 2000 Feb; 13(2):107-12. PubMed ID: 10697265
[TBL] [Abstract][Full Text] [Related]
10. Immunohistochemical marker panels for distinguishing between epithelioid mesothelioma and lung adenocarcinoma.
Kushitani K; Takeshima Y; Amatya VJ; Furonaka O; Sakatani A; Inai K
Pathol Int; 2007 Apr; 57(4):190-9. PubMed ID: 17316414
[TBL] [Abstract][Full Text] [Related]
11. Hepatocellular carcinoma with mesothelioma-like dissemination.
Otsuki Y; Shimizu S; Hosoda Y; Nagasawa M; Sato Y; Kobayashi H
Pathol Int; 2005 Nov; 55(11):738-44. PubMed ID: 16271087
[TBL] [Abstract][Full Text] [Related]
12. h-caldesmon, calretinin, estrogen receptor, and Ber-EP4: a useful combination of immunohistochemical markers for differentiating epithelioid peritoneal mesothelioma from serous papillary carcinoma of the ovary.
Comin CE; Saieva C; Messerini L
Am J Surg Pathol; 2007 Aug; 31(8):1139-48. PubMed ID: 17667535
[TBL] [Abstract][Full Text] [Related]
13. Morphological aspects as prognostic factors in malignant mesothelioma: a study of 58 cases.
Motta AB; Pinheiro G; Antonângelo L; Parra ER; Monteiro MM; Pereira JC; Takagaki T; Terra Filho M; Martins S; Capelozzi VL
J Bras Pneumol; 2006; 32(4):322-32. PubMed ID: 17268732
[TBL] [Abstract][Full Text] [Related]
14. Value of immunohistochemistry in the differential diagnosis of pleural sarcomatoid mesothelioma from lung sarcomatoid carcinoma.
Takeshima Y; Amatya VJ; Kushitani K; Kaneko M; Inai K
Histopathology; 2009 May; 54(6):667-76. PubMed ID: 19438742
[TBL] [Abstract][Full Text] [Related]
15. Lymphohistiocytoid mesothelioma of the pleura.
Kawai T; Hiroi S; Nakanishi K; Takagawa K; Haba R; Hayashi K; Kawachi K; Nozawa A; Hebisawa A; Nakatani Y
Pathol Int; 2010 Aug; 60(8):566-74. PubMed ID: 20618734
[TBL] [Abstract][Full Text] [Related]
16. [Cell-block immunocytochemical characterization of effusions. Use of antibody panel: calretinin, Ber-EP4, keratin and CD68].
Lucchi I; Morigi F; Naldi S; Tabarri B; Elegibili E; Giangaspero F
Pathologica; 1999 Dec; 91(6):447-52. PubMed ID: 10783640
[TBL] [Abstract][Full Text] [Related]
17. [A case of primary malignant retroperitoneal mesothelioma needed to differentiate adrenal tumor].
Kojima K; Tamaki M; Maeda S; Tashiro K; Takahashi Y; Yokoi S; Nishino Y; Deguchi T
Hinyokika Kiyo; 2002 Mar; 48(3):183-6. PubMed ID: 11993216
[TBL] [Abstract][Full Text] [Related]
18. Immunocytochemical panel for distinguishing between carcinoma and reactive mesothelial cells in body cavity fluids.
Politi E; Kandaraki C; Apostolopoulou C; Kyritsi T; Koutselini H
Diagn Cytopathol; 2005 Mar; 32(3):151-5. PubMed ID: 15690338
[TBL] [Abstract][Full Text] [Related]
19. Primary peritoneal mesotheliomas in children: a clinicopathological and immunohistochemical study of eight cases.
Moran CA; Albores-Saavedra J; Suster S
Histopathology; 2008 Jun; 52(7):824-30. PubMed ID: 18494612
[TBL] [Abstract][Full Text] [Related]
20. Immunocytochemical differential diagnosis of diffuse malignant pleural mesotheliomas--a clinicomorphological study of 158 cases.
Vortmeyer AO; Preuss J; Padberg BC; Kastendieck H; Schröder S
Anticancer Res; 1991; 11(2):889-94. PubMed ID: 1712181
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]